Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Celea Therapeutics Presents SURPASS-IPF Phase 3 Trial Design and Statistical Considerations for Evaluating Clinical Trials in Idiopathic Pulmonary Fibrosis at the IPF Summit 2026
-
Lufax Holding Ltd Announces Plan to Implement ADS Ratio Change
-
The Hartford Announces CEO Succession
-
UNISYNC Announces Normal Course Issuer Bid and Automatic Securities Purchase Plan
-
ACM Research’s Operating Subsidiary ACM Research (Shanghai) Provides Backlog Data
-
Enigmatig Limited Issues Statement on Recent Share Trading Activity
-
GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price
-
Ambow Launches HybriU Events On Demand, Bringing AI-Powered Hybrid Events to Venues in a Single Transport Case
-
Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)
-
Chilco River Holdings Advances Commercialization Across Premium Spirits Portfolio
-
NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depres
-
Beamr Expects Fiscal Year 2026 Revenues to Increase by $1.5 Million Year Over Year
-
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
-
ONAR Completes Largest Acquisition in Company History: Advertise Purple Adds $17.1 Million of Revenue and $4.4 Million of Net Income, Bringing Combined Pro Forma Revenue to Approximately $23.5 Million
-
Northland Power Closes Financing for Two Battery Storage Projects in Poland
-
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
-
10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher
-
Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy
-
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
-
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
-
FactSet Reports Results for Fourth Quarter and Fiscal 2026
-
GlobalFoundries Announces Conference Call to Review Third Quarter 2026 Financial Results
-
Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies
-
Chair of AB KN Energies Remuneration and Nomination Committee Elected
-
EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application
-
AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness
-
Clough Global Opportunities Fund Section 19(a) Notice
-
Clough Global Equity Fund Section 19(a) Notice
-
Reaves Utility Income Fund Section 19(a) Notice
-
Zoomlion Marks 34th Anniversary, Highlighting Milestones in Innovation and Global Growth
-
Dress for Success® Worldwide Hosts 2026 Women Who Inspire Luncheon with Special Tribute to Gloria Steinem by Julianna Margulies and Amy Richards
-
Pantheon Expands Middle East Presence With New Abu Dhabi Office and Senior Regional Appointment
-
Nexera Technologies: Subsidiary Fort Technology Targets the Growing Data Center Backup-Power Market Through Acquisition of Majority Stake in Logia USA
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
YieldMax® ETFs Announces Quarterly Distribution for the U.S. Stocks Target Double Distribution ETF (DDDD)
-
Rogers Corporation to Host Investor Day on September 30, 2026
-
Alamos Gold Provides Notice of Third Quarter 2026 Results and Conference Call
-
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
-
Shaping tomorrow's warehouse: Geekplus and LPP Logistics transform retail logistics through intelligent automation
-
MESCIUS USA, Inc. Recognized in 2026 ComponentSource Awards
-
What Is NumanCap? A Look at the Platform, Markets and Accounts
-
MAPFRE Brazil Increases Customer Retention from 1% to 40% and Protects Revenue within 60 Days of Implementing SuccessKPI AI-Powered Quality Management
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
ASCAR Reports EUR 1 Million+ Turnover in 2026 as Company Outlines 2027 Growth Outlook
-
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
-
34% of Global Consumers Say They Are Worse Off Financially Than a Year Ago as Households Adapt to a New Era of Permanent Uncertainty, NIQ Finds
-
Solidion Technology Chairman and CEO Jaymes Winters Justifies Below Market Acquisition Price for Flux Power, Inc. (Nasdaq: FLUX)
-
Jacobs to deploy data center digital twin for NVIDIA’s R&D facility
-
Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum
-
The Kayon Gangga Resort Opens in East Bali, Unveiling a New Luxury Sanctuary Rooted in Culture, Cuisine and Wellness
